Kendall Square Reached Inflection Point, Passing From Tech To Biotech Center

CAMBRIDGE, MA - SEPTEMBER 30: Scientist David Miller of Vaxess Technologies treated cells with vaccines at LabCentral in Cambridge, Mass. on September 30, 2014. (Photo by Wendy Maeda/The Boston Globe via Getty Images)
CAMBRIDGE, MA - SEPTEMBER 30: Scientist David Miller of Vaxess Technologies treated cells with vaccines at LabCentral in Cambridge, Mass. on September 30, 2014. (Photo by Wendy Maeda/The Boston Globe via Getty Images)
Kendall Square Reached Inflection Point, Passing From Tech To Biotech Center
PURCHASE A LICENCE
How can I use this image?
AED 1,850.00
AED

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.
Credit:
Boston Globe / Contributor
Editorial #:
456804288
Collection:
Boston Globe
Date created:
30 September, 2014
Upload date:
Licence type:
Release info:
Not released. More information
Source:
Boston Globe
Object name:
maeda_05Kirsner_photo_biz3
Max file size:
4714 x 4213 px (39.91 x 35.67 cm) - 300 dpi - 5 MB